Interpretation of the optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy
10.3760/cma.j.issn.0254-9026.2025.02.004
- VernacularTitle:《优化老年共病患者多重用药和处方精简策略》解读
- Author:
Hao GUO
1
;
Wenjing ZHANG
1
;
Gerile HUANG
1
;
Hongxin YANG
1
;
Ke ZHAO
1
Author Information
1. 内蒙古自治区人民医院药学处，呼和浩特 010017
- Publication Type:Journal Article
- Keywords:
Polypharmacy;
Comorbidity;
Formularies
- From:
Chinese Journal of Geriatrics
2025;44(2):130-135
- CountryChina
- Language:Chinese
-
Abstract:
Inappropriate polypharmacy is common in older patients with co-morbidities, and prescription streamlining can help to ensure the safety of medications for older patients with co-morbidities.In 2023, The Alliance of European Geriatrics Societies(AEGS)summarized the literature on medication review and prescription streamlining to propose 33 recommendations for optimizing polypharmacy and prescription streamlining in older patients with co-morbidities.The strategy suggests incorporating prescription streamlining into the daily practice of geriatricians and clinical pharmacists, and provides recommendations about education and training of clinical staff, development of disease guidelines, policy support, and clinical trial research in older adults aiming to improve the management of polypharmacy.This article explains the key elements of this strategy to provide reference for high-quality healthcare for elderly patients with co-morbid in China.
